C12R 1 - Micro-organisms - Patents Sitemap

Patents for C12R 1 - Micro-organisms (92,025)
11/2004
11/25/2004	US20040235140 Transgenic microorganism for use as bioreactor for expression of heterologous genes and proteins; antigen production and vaccine development
11/25/2004	US20040235120 Method for producing vitamin b12
11/25/2004	US20040235114 Immunogenic compounds
11/25/2004	US20040235091 Preparing protease resistant, bioactive amino acid sequences for use as therapeutic peptides; biodrugs; mimetics
11/25/2004	US20040235077 Luciferase and methods for measuring intracellular ATP using the same
11/25/2004	US20040234981 Method of determining dna base sequence
11/25/2004	US20040234553 Cold-adapted equine influenza viruses
11/25/2004	US20040234498 Inducing apoptosis in mammalian cancer cellsl stimulanting a proinflammatory response ; polypeptides; tumor necrosis factor
11/25/2004	US20040232205 Lantibiotic
11/24/2004	EP1479777A1 Method of producing astaxanthin by fermenting selected strains of xanthophyllomyces dendrorhous
11/24/2004	EP1479775A1 Process for producing l-threonine with the use of bacterium beloniging to the genus escherichia
11/24/2004	EP1479770A1 Surface expression libraries of randomized peptides
11/24/2004	EP1479763A2 Mutant luciferase having increased thermostability
11/24/2004	EP1479395A1 Modified factor VII
11/24/2004	EP1478777A2 Sequences specifically deleted from mycobacterium tuberculosis genome and their use in diagnosistics and as vaccines
11/24/2004	EP1478760A1 Esterases with lipase activity
11/24/2004	EP1478731A1 Phenalenone derivatives, method for the production thereof and use of the same
11/24/2004	EP1478662A1 Method for producing hypoallergenic major birch pollen allergens rbet v 1
11/24/2004	EP1276892B1 A bacterial two-hybrid system for protein interaction screening
11/24/2004	EP1200605B1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
11/24/2004	EP0904348B1 Process for the preparation of amino alcohols and derivatives thereof
11/24/2004	EP0826064B1 Low oxygen affinity mutant hemoglobin
11/24/2004	EP0755449B1 DNA SEQUENCES CODING FOR A CYNNAMOYL CoA REDUCTASE AND THEIR USE IN THE REGULATION OF PLANT LIGNIN CONCENTRATIONS
11/24/2004	EP0551438B1 Surface expression libraries of randomized peptides
11/24/2004	CN1549863A Process for producing acrylamide using a microbial catalyst having been wahed with aqueous acrylic acid solution
11/24/2004	CN1548533A Protease variant and composition
11/24/2004	CN1177054C D-sorbitol dehydrogenase gene
11/24/2004	CN1177045C Trehalose synthase protein, gene, plasmides, microoganisms, and a process for producing trehalose
11/24/2004	CN1177035C Bacterial consortium EBC1000 and method using bacterial consortium EBC 1000 for remedying biologically recalcitrant toxic chemicals contained in industrial waste water etc.
11/23/2004	US6822141 Diacylglycerol acyl transferase proteins
11/23/2004	US6822137 Nucleotide sequence encoding the enzyme I-SCEI and the uses thereof
11/23/2004	US6822075 Protein for use in the diagnosis and treatment of autoimmune, cancer and viral disorders
11/23/2004	US6821768 Corynebacterium ammoniagenes KCCM 10340 for producing 5'-xanthylic acid
11/23/2004	US6821766 Thermostable creatine amidinohydrolase and process for producing the same
11/23/2004	US6821754 Staphylococcus aureus genes and polypeptides
11/23/2004	US6821749 Methods of producing carotenoids using DNA molecules encoding isopentenyl pyrophosphate isomerase
11/23/2004	US6821743 Membrane protein for use in controlling vasodilation
11/23/2004	CA2116026C Hepatitis c assay utilizing recombinant antigens to c-100 region
11/23/2004	CA2084076C Family of map2 protein kinases
11/23/2004	CA2012482C Hepatitis c diagnostics and vaccines
11/18/2004	WO2004099425A2 Pyruvate producing yeast strain
11/18/2004	US20040230038 Process for the stabilization of proteins in complex mixtures during their storage in aqueous solvents
11/18/2004	US20040230037 Chemokine receptor materials and methods
11/18/2004	US20040229788 Cell surface molecule mediating cell adhesion and signal transmission
11/18/2004	US20040229339 Comprises neisseria membrane protein for use as tool in generation of vaccine to prevent infection and sepsis in infants
11/18/2004	US20040229328 Process for immobilized nano-sized metal particles
11/18/2004	US20040229325 Obtaining docosahexaenoic acid from microorganisms comprising: lysing cells, forming separate layers, recover docosahexaenoic acid lighter layer
11/18/2004	US20040229320 Method for procucing L-amino acid using bacterium, belonging to the genus Escherichia, lacking active mlc gene
11/18/2004	US20040229311 Enzymatic protein comprising lysine decarboxylase activity for biosynthesis of lysine in transgenic methylophilus; bioreactors
11/18/2004	US20040229212 Recombinant human mannan-binding lectin
11/18/2004	US20040228857 administration of a human or humanized antibody expressed and glycosylated in a chinese hamster ovaries (CHO) cell expression system to treat T-cell mediated disorders, autoimmune disorders, cancer and infections; vasculitis, arthritis, lupus, psoriasis, multiple sclerosis, graft versus host disease
11/18/2004	US20040228840 Vector for integration of heterologous sequences into poxviral genomes
11/18/2004	DE10317877A1 Verfahren zur Herstellung von Sporidiobolus ruineniae Stämmen mit verbesserter Coenzym Q10-Produktion Process for the preparation of Sporidiobolus ruineniae strains with improved coenzyme Q10 production
11/18/2004	CA2524262A1 Pyruvate producing yeast strain
11/17/2004	EP1477565A1 Method of producing L-lysine by fermentation
11/17/2004	EP1477563A2 Cloning genes from streptomyces cyaneogriseus subsp.noncyanogenus for biosynthesis of antibiotics and methods of use
11/17/2004	EP1477562A1 Transcriptional factor, transcriptional factor gene, recombinant vector containing transcriptional factor gene, koji-mold transformed by the vector and method of using koji-mold
11/17/2004	EP1477558A1 Selection methods
11/17/2004	EP1477557A1 transgenic plant resistant to mycotoxins and methods
11/17/2004	EP1477497A1 Humanized immunoglobulins and their production and use
11/17/2004	EP1476580A2 Multiple virus replicon culture systems
11/17/2004	EP1476546A2 Functionalization of carotenoid compounds
11/17/2004	EP1476544A1 Enone reductase
11/17/2004	EP1476539A2 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
11/17/2004	EP1476454A1 Binding epitopes for helicobacter pylori and use thereof
11/17/2004	EP1254229B1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof
11/17/2004	EP1171000B1 Novel protective cultures and use thereof for preserving foodstuffs or feedstuffs
11/17/2004	EP1105503B1 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE ALPHA1/BETA1 (hsGCALPHA1/BETA1)
11/17/2004	EP1054994B1 Fermentative preparation process for cytostatics and crystal forms thereof
11/17/2004	EP1040193B1 Promoter from ashbya gossypii
11/17/2004	EP0919628B1 Process for producing high-molecular-weight compounds of phenolic compounds, etc. and use thereof
11/17/2004	EP0801657B1 Retinoid x receptor-interacting polypeptides and related molecules and methods
11/17/2004	EP0731811B1 Chaperonin 10
11/17/2004	EP0726957B1 RECOMBINANT DNase B DERIVED FROM STREPTOCOCCUS PYOGENES
11/17/2004	EP0603263B1 Yeast artificial chromosomes and their use in transformation of embryonic stem cells
11/17/2004	CN1547610A DNA for achieving high expression of growth hormone and use thereof
11/17/2004	CN1547609A Improved process for converting nitriles to carboxylic acids using nitrilase
11/16/2004	US6818664 Antitumor agent which comprises said compound or a physiologically acceptable salt thereof as an active ingredient.
11/16/2004	US6818611 Stabilized bioactive peptides and methods of identification, synthesis and use
11/16/2004	US6818581 Method for water denitrification
11/16/2004	US6818445 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/16/2004	US6818426 (R)-2,3-butanediol dehydrogenase
11/16/2004	US6818424 Generation of preferential terpenes; obtain genetically engineered cell, incubate with preferential substrates, recover terpenes
11/16/2004	US6818409 Isolation and purification of Clostridium botulinum toxins
11/16/2004	US6818230 Antiproliferative effect can be achieved by subjecting conditioned medium obtained by culturing the structures of the invention in culture medium to filtration; anticancer agents
11/16/2004	US6817317 Animal papilla disinfectants and method of improving microbial environment
11/16/2004	CA2265949C Sordarin and derivatives thereof for use as crop antifungal agents
11/16/2004	CA2120342C Epstein-barr virus peptides and antibodies against these peptides
11/16/2004	CA2116003C Arylalkanoic acid resolution
11/16/2004	CA2074719C Calcium channel compositions and methods
11/16/2004	CA2059692C Pneumoccoccal polysaccharide conjugate vaccine
11/11/2004	WO2004097530A1 Structure and method for producing structure, toner containing structure, image forming method and device using toner
11/11/2004	WO2004096246A1 Antiallergic composition
11/11/2004	WO2004096188A1 Polyhydroxyalkanoate-containing magnetic structure, and manufacturing method and use thereof
11/11/2004	US20040225114 IGF-1 receptor interacting proteins
11/11/2004	US20040224393 Modified human granulocyte-colony stimulating factor and process for producing same
11/11/2004	US20040224388 Hyphal growth in fungi
11/11/2004	US20040224386 Protein tyrosine kinases
11/11/2004	US20040223968 inhibiting a condition characterized by monocytic infiltrates such as atherosclerosis by administering an MCP-1 receptor antagonist that binds to an MCP-1 receptor polypeptide, especially a humanized or monoclonal antibody.
11/11/2004	CA2518947A1 Antiallergic composition

1 ... 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 ... 921